Brookfield is building the Apollo machine and the market hasn't priced it in

Brookfield's $30 billion insurance bet is the most important move in alt finance this year

Bruce Flatt has been doing this long enough to know that the best trades don't feel exciting when you're making them. They feel obvious in hindsight.

On Wednesday's earnings call, Flatt opened with a real estate trade that most managers would have led with as the headline. A $1.9 billion non-recourse mortgage on 2 Manhattan West, priced at 107 basis points over Treasuries, rents nearly three times the first lease signed in the complex, and $400 million of net cash pulled out the door. That is not a story about commercial real estate recovering. That is a story about what happens when you buy distressed assets at the right price and hold them long enough for the world to come back to you.

But the trade that matters more is the one most people on the call were treating as administrative: the BWS combination. Brookfield Corporation (NYSE:BN) is folding $30 billion of insurance value into the parent and giving that insurance operation access to $145 billion of permanent capital. The shareholder vote is July 16.

The comparison that should be in your head is Apollo Global Management (NYSE:APO). Apollo spent the better part of a decade building an integrated model where insurance liabilities (through Athene) feed permanent capital into its credit and alternatives business, and the alternatives returns flow back to satisfy those liabilities. It is a perpetual motion machine for fee revenue and AUM growth. Apollo's market cap reflects how well that machine works.

Brookfield is building the same machine, and the market hasn't priced it in yet.

Sachin Shah was the sharpest voice on the call. He laid out a deliberate geographic sequencing: the UK pension risk transfer market, where Just Group is already targeting both very small and very large schemes because the mid-market is crowded, and then Japan as an early reinsurance beachhead. He was specific about why those two markets. The UK has a structural surplus of defined benefit pension liabilities looking for a home. Japan has an aging population with decades of savings sitting in low-yield government bonds that need to be put to work. Both markets are underpenetrated by the Apollo-style integrated alt manager.

If BWS can run the US annuity distribution playbook in the UK and Japan over the next five years, the insurance earnings line at BN could double without Brookfield taking on meaningful additional credit risk. The capital is already there. The distribution build is the work.

The CFO, Nick Goodman, was measurably tighter in Q&A than in prepared remarks. Filler rates jumped, and there was a noticeable pause before he fielded the industry consolidation question. That tells you Brookfield is watching the private credit and alt manager contagion more carefully than the answer implied. It's a real risk. If credit spreads widen sharply and insurance liabilities need to be marked, the integrated model that makes Apollo look brilliant in good times can amplify pain quickly.

But the base case is this: July 16 is a catalyst, the geographic insurance expansion is a five-year compounder, and BN is still trading at a discount to the sum of its parts. The market hasn't caught up to what Brookfield is actually building.

✦

Quick Takes

Three more stories worth knowing about

Veeva's AI pricing model is stranger than it sounds, and that's the point

Veeva Systems (NASDAQ:VEEV) CEO Peter Gassner described outcome-based AI pricing with a strawberry-picking analogy on Wednesday's call. You pay per document processed, per safety case resolved. It sounds niche until you map it: Veeva now measures physician engagement through CrossX, drives traffic to physicians via Austro, and will automate responses through Vault AI agents. That is a closed loop across the entire biopharma commercial and safety workflow. The Austro acquisition isn't a bolt-on feature. It's the commercial intelligence layer that companies like Doximity (NASDAQ:DOCS) should be genuinely worried about. Management's conservatism on AI revenue this year reads less like uncertainty and more like they aren't ready for the market to price what's coming.

SpaceX's IPO window is narrowing fast

Multiple reports now point to a SpaceX IPO as early as this month, with valuation estimates around $1.75 trillion. If that lands, the immediate market reaction won't be about SpaceX itself. It'll be about everything adjacent. Rocket Lab (NASDAQ:RKLB) is the only other public company with an operational orbital launch vehicle. AST SpaceMobile (NASDAQ:ASTS) is building the satellite broadband thesis SpaceX proved works. Intuitive Machines (NASDAQ:LUNR) literally launches on Falcon 9 and holds NASA contracts. None of these are SpaceX. But when a $1.75 trillion IPO hits, institutional money looking for exposure to the sector doesn't have many places to go.

Golden Dome funding is moving faster than the contracts

The administration's missile defence push is real, the budget allocations are real, but the actual contract awards are still trailing the rhetoric. That gap is where the risk sits for investors who bought LMT, RTX, and KTOS on the announcement headlines. Lockheed Martin (NYSE:LMT) and RTX (NYSE:RTX) have the incumbent positions in missile defence architecture, and they'll win when the money flows. Kratos (NASDAQ:KTOS) is the asymmetric angle if the program broadens to distributed autonomous systems. The trade isn't dead, it's just waiting for the procurement machinery to catch up to the political will.

✦

Overlooked Stock

CRDO

Credo Technology Group Holding Ltd

Every conversation about AI infrastructure gravitates toward Nvidia. The chips that train the models get the headlines. What gets less attention is the copper and optical interconnect layer that keeps those chips talking to each other at the speeds required for large-scale training clusters.

Credo Technology Group (NASDAQ:CRDO) makes active electrical cables and high-speed SerDes chiplets that sit between the GPUs, the network switches, and the optical modules in hyperscaler data centers. Its HiWire active electrical cables solve a specific physics problem: as cluster sizes grow, passive copper cables lose signal integrity at the lengths required. Active electrical cables extend that reach without forcing an immediate jump to expensive optical.

The customer list is hyperscalers and large OEMs, which means the revenue is tied directly to data center buildout spending. Credo scored a 92 in our system. It is not a household name. That is precisely why it's worth looking at.

The Contrarian Take

The FICO score monopoly is more fragile than the stock price suggests

Fair Isaac Corporation (NYSE:FICO) trades like a toll booth that can raise prices forever. The score is embedded in every mortgage origination, every credit card approval, every auto loan underwriting process in America. That kind of penetration feels permanent.

But the pressure building on both sides is real. The CFPB under various administrations has pushed periodically to reduce FICO's gatekeeper role in mortgage underwriting. Fannie Mae and Freddie Mac have been moving toward accepting VantageScore as an alternative. And the AI underwriting wave, where lenders train proprietary models on their own default data, steadily erodes the argument that a third-party score is necessary at all.

None of this kills FICO tomorrow. The switching costs are enormous and the regulatory entrenchment is deep. But a stock priced for perpetual pricing power in a business facing structural challenges from regulators, government-sponsored enterprises, and AI-native lenders deserves more scepticism than it currently gets.